Skip to main content
logo
Avadel Pharmaceuticals plc (AVDL)
21.64
+0.01 (0.05%)
Inactive · Last trade price on Feb 11, 2026

Avadel Pharmaceuticals Stock Forecast

Stock Price Forecast

The 8 analysts with 12-month price forecasts for Avadel Pharmaceuticals stock had an average target of $19.14, with a low estimate of $12 and a high estimate of $22.5.

Price Target: $19.14 (-11.55%)
Analyst Consensus: Buy

Price Target

TargetLowAverageMedianHigh
Price$12$19.14n/a$22.5
Change-44.55%-11.55%n/a+3.97%

Analyst Ratings

The average analyst rating for Avadel Pharmaceuticals stock from 8 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.

Recommendation Trends

No data available
RatingOct 2026
Strong Buyn/a
Buyn/a
Holdn/a
Selln/a
Strong Selln/a
Totaln/a

Financial Forecast

Revenue This Year
279.84M
from 169.12M
Increased by 65.47%
Revenue Next Year
366.25M
from 279.84M
Increased by 30.88%
EPS This Year
0.20
from -0.51
EPS Next Year
0.83
from 0.20
Increased by 313.31%
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
22.33M--27.96M169.12M279.84M366.25M
Revenue Growth
-62.28%---504.79%65.47%30.88%
EPS
0.13-1.32-2.29-2.00-0.510.200.83
EPS Growth
------313.31%
Forward PE
-----108.4026.23
No. Analysts
-----1212

Revenue Forecast

Revenue202520262027202820292030
High295.2M397.2M
Avg279.8M366.3M
Low261.7M338.2M

Revenue Growth

Revenue Growth202520262027202820292030
High
74.5%
41.9%
Avg
65.5%
30.9%
Low
54.7%
20.9%

EPS Forecast

EPS202520262027202820292030
High0.361.20
Avg0.200.83
Low0.110.57

EPS Growth

EPS Growth202520262027202820292030
High-
499.6%
Avg-
313.3%
Low-
184.7%